Prescription drug · UNAPPROVED DRUG OTHER
RenThyroid (Levothyroxine and liothyronine) NDC 64950-175
Levothyroxine 114 ug/1; Liothyronine 27 ug/1 · Tablet · Oral · Genus Lifesciences
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64950-175-01 | 6495001750164950017501 | 100 TABLET in 1 BOTTLE (64950-175-01)Marketed from Mar 1, 2025 | |
| 64950-175-09 | 6495001750964950017509 | 90 TABLET in 1 BOTTLE (64950-175-09)Marketed from Mar 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- RenThyroid
- Generic name (nonproprietary)
- levothyroxine and liothyronine
- Active ingredients
- Levothyroxine — 114 ug/1Liothyronine — 27 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Genus LifesciencesNDC labeler code 64950
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 64950-175_dd8b277c-6ec2-4e0b-9aec-c64089e18cfeSPL ID dd8b277c-6ec2-4e0b-9aec-c64089e18cfeSPL set ID 0f0c1875-7706-43ec-a9ef-ad82a49e46ecRxCUI 198278, 208545, 313387, 313391, 313393, 314267, 2706315, 2706317, 2706319, 2706321, 2706323, 2706325, 2706327, 2706329, 2706331, 2706333UNII 06LU7C9H1V, Q51BO43MG4UPC 0364950171013, 0364950170016, 0364950180015, 0364950175011, 0364950172010, 0364950173017, 0364950179019, 0364950174014
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464950017501followed by a unit qualifier and the quantityPackage 64950-0175-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE RenThyroid (Thyroid Tablets, USP) are indicated: As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS ). As …
Excerpt only. Read the full label for complete information.
About NDC 64950-175
- What is NDC 64950-175?
- 64950-175 is the product NDC for RenThyroid, Levothyroxine 114 ug/1; Liothyronine 27 ug/1 tablet, listed with the FDA by Genus Lifesciences. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- RenThyroid (LEVOTHYROXINE and LIOTHYRONINE).
- What is the active ingredient?
- Levothyroxine, Liothyronine.
- Who is the labeler?
- Genus Lifesciences, NDC labeler code 64950. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for RenThyroid?
- 7 other product NDCs are listed under this name. See all RenThyroid NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other RenThyroid products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| RenThyroidlevothyroxine and liothyronine | Levothyroxine 9.5 ug/1; Liothyronine 2.25 ug/1 | TabletOral | Genus Lifesciences | 64950-170 | 64950-0170-0164950-0170-0964950-0170-14 |
| RenThyroidlevothyroxine and liothyronine | Levothyroxine 19 ug/1; Liothyronine 4.5 ug/1 | TabletOral | Genus Lifesciences | 64950-171 | 64950-0171-0164950-0171-0964950-0171-14 |
| RenThyroidlevothyroxine and liothyronine | Levothyroxine 38 ug/1; Liothyronine 9 ug/1 | TabletOral | Genus Lifesciences | 64950-172 | 64950-0172-0164950-0172-0964950-0172-14 |
| RenThyroidlevothyroxine and liothyronine | Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 | TabletOral | Genus Lifesciences | 64950-173 | 64950-0173-0164950-0173-0964950-0173-14 |
| RenThyroidlevothyroxine and liothyronine | Levothyroxine 76 ug/1; Liothyronine 18 ug/1 | TabletOral | Genus Lifesciences | 64950-174 | 64950-0174-0164950-0174-0964950-0174-14 |
| RenThyroidlevothyroxine and liothyronine | Levothyroxine 28.5 ug/1; Liothyronine 6.75 ug/1 | TabletOral | Genus Lifesciences | 64950-179 | 64950-0179-0164950-0179-0964950-0179-14 |
| RenThyroidlevothyroxine and liothyronine | Levothyroxine 47.5 ug/1; Liothyronine 11.25 ug/1 | TabletOral | Genus Lifesciences | 64950-180 | 64950-0180-0164950-0180-0964950-0180-14 |